All Type of News
Domestic pharmaceutical industry expected to narrowly grow in 2016
It was expected the domestic pharmaceutical market will narrowly grow and market shares of the top companies will rally in 2016. Exportation of pharmaceutical products is anticipated to grow smoothly through the incre...
Impossibility to coexist between antidiabetic DPP-4 and SGLT-2
The product groups, which have currently attracted the most interests of the domestic diabetes market, are the ‘SGLT-2 inhibitor’ type and the ‘DPP-4 inhibitors’ type.
Domestic influential pharmaceutical companies t...
Keen interests in J.P. Morgan and Hanmi at the partnering event
The new drug technology market is booming. As the Open Innovation strategy has become the trend to introduce foreign technology due to the limitation in the own capability, domestic companies have been concentrated to...
‘Flying pharmaceutical stocks’ rapidly increased by 9% despite unfavorable factors
Despite unfavorable factors, ‘Black New Year Started in China’ and ‘North Korea Nuclear Bomb Test,’ pharmaceutical stocks have still remain super strong. The securities market is now paying attention to who will be th...
KPA responds to the notification of card fee raise on pharmacies
The pharmaceutical association has started to respond to unexpected notifications of credit card companies to raise fees.
On the 7th, the Korean Pharmaceutical Association(President Chan-hui Cho, KPA) pressed the Fin...
Self-sufficiency of the 20 essential vaccines by 2020
The government may be able to manufacture all the 20 vaccines registered for the national immunization by 2020 in the domestic industry.
The Ministry of Food and Drug Safety announced development of the test method f...
5 companies to join in KRW 1 Trillion Club in pharmaceutical industry last year
The total 5 companies were tentatively aggregated to record more than KRW 1 trillion in the pharmaceutical and pharmaceutical distribution industry last year.
In the pharmaceutical industry, Yuhan Corporation achieve...
Pfizer introduces a new HER2-negative breast cancer targeted treatmentA targeted therapy for HER2-negative patients is expected to be introduced in the domestic market.
According to the industry concerned on the 7th, Pfizer Pharmaceuticals Korea ...
|
Which company will achieve global technology exports this year?
Domestic pharmaceutical companies, which experienced the Hanmi Pharm’s surprising technology exports worth of trillions of wons last year, have not turned off lights of their laboratories.
According to the ‘Top 10 Ph...
Avastin dilemma accusing normal ophthalmologists for criminals
‘Avastin(generic name: bevacizumab),’ which has been widely used without approval as the age-related macular degeneration treatment, has been in a dilemma.
Recently, an ophthalmologist who injected Avastin to treat m...
